Roche Partners With Hansoh in Deal That Could Exceed $15 Billion
Roche Holding entered a collaboration and licensing agreement with China's Hansoh Pharmaceutical Group. Hansoh will receive $400 million upfront and $110 million after a year, with eligibility for potential additional payments.